Today: 22 June 2026

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo Nordisk launched an $8.5 billion unsolicited bid for obesity drugmaker Metsera, topping Pfizer’s $7.3 billion agreed deal. Novo’s offer values Metsera at $56.50 per share in cash plus up to $21.25 in milestone payments. Metsera shares jumped 18% premarket, while Novo’s stock fell 3%. Pfizer called Novo’s bid “reckless” and warned it could harm competition.
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck shares fell about 2% after hours Oct. 30 despite Q3 revenue of $17.28 billion and $2.58 adjusted EPS, both above estimates. Keytruda sales rose 10% to $8.1 billion. The company narrowed its 2025 sales outlook and raised profit guidance. Recent milestones include FDA approval of subcutaneous Keytruda and the $10 billion acquisition of Verona Pharma.
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks shares soared 377% to $2.95 on Oct 29 after announcing integration of its ONE Network platform with SpaceX’s Starlink. After-hours trading pushed the stock as high as $6.69. The rally followed recent Nasdaq delisting warnings and a CFO departure. Cambium’s market cap reached about $83 million, with analysts split on the outlook amid ongoing losses and volatile trading.
30 October 2025
VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCIG shares jumped 87.8% in after-hours trading Oct. 29 to $3.38 after announcing its Smart Bridge unit will exclusively manage 1 billion XVIQ AI/GPU crypto tokens. The stock quickly fell back to around $1.80 by midday Oct. 30. VCIG recently guided for 2025 revenue of $47.3 million, up 70% year-over-year, and plans to launch a gold-backed crypto platform by Q2 2026. Market cap remains about $2–3 million.
Inside Samsung: How the Tech Giant is Dominating Every Industry It Touches

Samsung Stock Soars on AI Chip Boom – Q3 Earnings Crush Estimates

Samsung Electronics shares jumped 3.6% to ₩104,100 on October 30, hitting a 52-week high after Q3 revenue reached ₩86.1 trillion and operating profit rose 32% to ₩12.2 trillion, fueled by record AI chip sales. The company plans major expansion of high-bandwidth memory production for AI servers. Samsung also launched its first Galaxy XR headset and announced a DRAM supply deal with OpenAI.
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOG) Hits Record High on Q3 Earnings Beat, AI Boom Fueling Rally

Alphabet shares jumped 6% to a record high near $270 on Oct. 30 after third-quarter earnings and revenue beat forecasts. Google’s ad revenue rose 12.6% to $74.2 billion, and cloud sales surged 34% to $15.16 billion. The company raised 2025 capital spending to as much as $93 billion for AI and cloud expansion. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Chipotle shares plunged 18% pre-market Oct. 30 after management cut its 2025 same-store sales forecast to a low-single-digit decline, citing persistent macroeconomic pressures. Q3 revenue rose 7.5% to $3.0 billion, but same-store sales grew just 0.3% as customer traffic fell for the third straight quarter. Chipotle opened 84 new restaurants and repurchased $686.5 million in stock. The stock is down 34% year-to-date.
Fiserv Earnings Miss Expectations, Shares Slide – What’s Next for the Fintech Giant?

Shock Selloff: Fiserv (FI) Stock Plunges 40% After ‘Shockingly Bad’ Q3, Major Shakeup Unveiled

Fiserv shares plunged about 42% to a 52-week low near $66 on Oct. 29, 2025, after missing Q3 estimates and slashing 2025 guidance. Adjusted EPS came in at $2.04 on $4.92 billion revenue, both well below forecasts. CEO Mike Lyons announced a turnaround plan and major leadership changes. The company will move its listing from NYSE to Nasdaq on Nov. 11.
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Nears All-Time High on AI, Cloud Boom – Is $625 Next?

Microsoft shares traded near $541 on Oct. 30, close to a 52-week high, with a market cap over $4 trillion after strong Q1 FY2026 results. Revenue rose 18% to $77.7 billion, driven by 40% Azure growth; EPS beat forecasts. Microsoft signed a $17.4 billion GPU cloud deal and joined a $40 billion data center consortium to expand AI capacity. Analysts set 12-month price targets near $620–650.
MP Materials Stock Soars on Pentagon and Apple Breakthroughs – 400% YTD Rally Explained

MP Materials Stock Surges on Rare-Earth Export Truce – Analysts Weigh In

MP Materials closed at $64.29 on Oct. 29, down from a mid-October peak of $100.25 after U.S.–China trade news triggered a sharp pullback. Shares remain up nearly 300–380% year-to-date, fueled by a $400 million U.S. Defense Department investment and a $500 million Apple supply deal. MP remains unprofitable, posting a Q2 loss of $0.13 per share despite 84% revenue growth. Analyst consensus targets average $77.80.
30 October 2025
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Powell’s Hawkish U-Turn and Trump–Xi ‘Mini-Deal’ Leave S&P 500 Futures on Edge

The Fed cut rates by 25 basis points to 3.75–4.00% on Oct 29, but Chair Powell warned a December cut is “not a foregone conclusion.” Nasdaq closed at a record 23,958, while S&P 500 was flat and Dow slipped. Trump announced a one-year “mini-deal” with China, easing some tariffs. Big Tech earnings were mixed: Nvidia rose, Microsoft and Meta fell, Alphabet surged.
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

Eli Lilly reported Q3 2025 revenue of $17.60 billion, up 54% year-over-year, and raised full-year EPS guidance to $23.00–23.70. Shares closed at $813.53 on Oct. 29, down 2% over the week after hitting highs above $850 earlier in the month. The FDA approved Inluriyo for metastatic breast cancer, and the EU cleared Kisunla for early Alzheimer’s. Wall Street’s average 12-month price target stands near $939.
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Stock Skyrockets on AI Push – Will It Keep Soaring?

Meta shares closed at $752 on Oct. 29, near record highs, before dipping up to 9% after mixed Q3 results and then rebounding. Q3 revenue rose 26% to $51.24 billion, but a $15.9 billion tax charge cut GAAP EPS to $1.05. Meta announced a $27 billion AI data center project in Louisiana and plans to buy AI-chip startup Rivos for $2 billion. The company also launched Ray-Ban Meta “Display” glasses, which quickly sold out.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

US stocks fell Oct. 30, with the S&P 500 down 0.99% and Nasdaq off 1.57%. Oracle shares dropped 6.8% to $256.28 despite analysts raising price targets and maintaining buy ratings. Liberty Latin America slid about 6% in a month, closing near $7.77, well below its $10.63 fair value estimate. Intensity Therapeutics surged nearly 400%, while CERO plunged almost 95%.
Klarna (KLAR) Stock Dives Below IPO Level – Analysts Eye 30%+ Rebound

Klarna’s Wild Post-IPO Ride: Stock Slump, New Deals & Experts Predict What’s Next

Klarna raised $1.37 billion in its September 2025 New York IPO at $40 per share, valuing the company at $15 billion. Shares jumped 30% on debut before dropping below the IPO price and trading in the mid-to-high $30s by late October. Klarna has launched new products in the UK and secured a Walmart partnership. The company remains near profitability after five straight quarters of operating profit.
OpenAI’s DevDay Bombshells: No-Code AgentKit, ChatGPT App Store & Jony Ive’s AI Vision

OpenAI’s Next Era: GPT-5 Revolution, $500 B Overhaul, and an AI Arms Race Ignites

OpenAI launched GPT-5 on August 7, making it the default for all 700 million ChatGPT users and enabling multimodal input, deep reasoning, and 400k-token context. The company completed a $500 billion restructuring in October, giving its nonprofit arm control of a new for-profit entity and reducing Microsoft’s stake to 27%. OpenAI signed major chip deals with AMD and Nvidia, sending AMD shares up 30%.
Massive Cybersecurity Storm: Ransomware Rampages, Mega-Breach Scare & Global Outages

Massive Cybersecurity Storm: Ransomware Rampages, Mega-Breach Scare & Global Outages

A DNS issue at Microsoft disrupted Azure and Microsoft 365 logins worldwide. A leak exposed 183 million stolen credentials, mainly Gmail, though Google said its servers were not breached. Dentsu and WestJet confirmed data breaches; hacktivists targeted Canadian infrastructure. New ransomware and malware strains surfaced, while CISA warned of active exploits in enterprise software.
30 October 2025
Home EV Charging Revolution: Government Axes Red Tape to Help Millions Without Driveways

Home EV Charging Revolution: Government Axes Red Tape to Help Millions Without Driveways

The UK government will scrap planning permission requirements for cross-pavement EV charging gullies, allowing street-parked electric cars to charge at home. The move could save drivers up to £250 in application fees and cut installation delays. About 9 million UK households without driveways stand to benefit. New rules will also require EV chargepoints in covered car parks and limit landlord markups on electricity.

Stock Market Today

  • National Australia Bank Shares Potentially 9.1% Undervalued Amid Data Strategy
    June 21, 2026, 5:49 PM EDT. National Australia Bank (ASX:NAB) shares trade at A$37.74, reflecting a 9.1% potential undervaluation with a fair value estimate of A$41.53. The bank is enhancing customer and operational insight access through Databricks' Genie-powered conversational analytics tool. Despite recent share price volatility-a 3.4% rise over seven days but a 17.18% fall over 90 days-NAB shows strong five-year total shareholder returns of 83.69%. Accelerated digital payment adoption and capital-light initiatives drive revenue growth prospects. However, competition from fintech and risks in asset quality could impact performance. NAB's price-to-earnings ratio of 18.9x exceeds global and peer averages but is below its fair value multiple of 20.5x, suggesting room for upside.

Latest articles

Infosys drops after Accenture forecast adds to Indian IT pressure

Infosys stock heads into the week after Accenture news hits Nifty IT

21 June 2026
Infosys plunged 6.75% to ₹1,051.40 after Accenture cut its fiscal 2026 revenue growth outlook, triggering a sector-wide selloff that sent Nifty IT to a three-year low; investors are reassessing Indian IT stocks as hopes for a demand recovery fade, with analysts warning that slow growth and delayed client spending could keep valuations under pressure ahead of Infosys’ July 23 earnings.
Six Fiserv Insiders Bought $1.72M of NASDAQ: FISV Ahead of Holiday

Six Fiserv Insiders Bought $1.72M of NASDAQ: FISV Ahead of Holiday

21 June 2026
Six Fiserv insiders bought 34,781 shares for $1.72 million after CEO Mike Lyons’ abrupt exit, but FISV closed at $47.86—down 3.4% from their $49.55 average price and 10.9% since the leadership change—leaving the group with a $58,783 paper loss as the stock trades at just 5.8–6.0 times reaffirmed 2026 adjusted EPS guidance, with investors awaiting proof of a turnaround.
Go toTop